US IVD Market Future Discussed in New Report Recently Published at MarketPublishers.сom

Share Article

New research report “The US In Vitro Diagnostics Market Outlook: Strategic Implications of Emerging Reimbursement, Technological and Market Trends through 2018” prepared by Venture Planning Group has been recently published by Market Publishers Ltd.

marketpublishers.com

Market Publishers Ltd

How will the future reimbursement changes affect individual market segments? Will the industry consolidate, decentralize, or undergo a bimodal transformation? What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export? How will the future technological advances affect the major market segments? Which companies will enter the market and which will not survive? The answers to all these and other key strategic questions can be found in the research report.

New research report “The US In Vitro Diagnostics Market Outlook: Strategic Implications of Emerging Reimbursement, Technological and Market Trends through 2018” prepared by Venture Planning Group has been recently published by Market Publishers Ltd.

Report Details:

Title: The US In Vitro Diagnostics Market Outlook: Strategic Implications of Emerging Reimbursement, Technological and Market Trends through 2018
Published: January, 2012
Pages: 135
Price: US$ 4,850
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/us_in_vitro_diagnostics_market_outlook_strategic_implications_of_emerging_reimbursement_technological_n_market_trends_through_2018.html

The report delves into in-depth analysis of the U.S. in vitro diagnostics market’s future. It evaluates emerging markets and technologies presenting unexpected threats or offering opportunities; features major regulatory, economic, demographic and social trends; as well as offers five- and ten-year test volume and sales forecasts for key testing locations and laboratory disciplines.

Market segments covered in the report include: clinical chemistry and immunodiagnostics, microbiology and serology, hematology and flow cytometry, blood banking, histology and cytology, coagulation, urinalysis.

Technologies covered include: molecular diagnostics, monoclonal antibodies, solid phase chemistry, biosensors and biochips, automation and robotics, IT.

Report Contents:

1. Executive Summary

2. Conclusions and Recommendations

3. Business Environment

a. Health Care Expenditures
b. Cost-Consciousness
c. Reimbursement
d. Industry Consolidation
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Aging Population
    More Chronic Illnesses
    Higher Incidence of Disease
    Greater Susceptibility to Iatrogenesis
    More Cases with Multiple Illnesses

4. Outlook for the In Vitro Diagnostics Market

a. Government Regulations
b. FDA Reform
c. Hospitals
d. Commercial Laboratories
e. Physician Offices
f. Point-of-Care Testing
g. Personal Testing
h. Other Testing Locations

5. Strategic Implications

a. Testing Patterns
    Test Utilization
    Pre-Admission Testing
    Inpatient Testing
    Outpatient Testing

6. Market Segments

a. Clinical Chemistry and Immunodiagnostics
    Introduction
    Future Situation
b. Microbiology and Serology
    Introduction
    Future Situation
c. Hematology and Flow Cytometry
    Introduction
    Future Situation
d. Blood Banking
    Introduction
    Future Situation
e. Histology and Cytology
    Introduction
    Future Situation
f. Coagulation
    Introduction
    Future Situation
g. Urinalysis
    Introduction
    Future Situation

7. Technologies

a. Molecular Diagnostics
    Introduction
    Future Situation
b. Monoclonal Antibodies
    Introduction
    Future Situation
c. Solid Phase Chemistry
    Introduction
    Future Situation
d. Biosensors and Biochips
    Introduction
    Future Situation
e. Automation and Robotics
    Introduction
    Future Situation
f. IT
    Introduction
    Future Situation

8. The New Marketplace

a. Purchasing Influences
b. Marketing Strategies
c. Joint Venture, Merger, and Licensing Activity
d. Import-Export
e. Potential Market Entrants
f. Who May Not Survive?

List of Tables

Executive Summary Table: Growth Areas in Clinical Laboratory Testing
Table-1: Estimated U.S. Health Care Expenditures By Expenditure Type
Table-2: Health Plan Enrollment Distribution
Table-3: Selected Hospital Statistics
Table-4: Total Population And Physician Demographics
Table-5: Test Volume By Location
Table-6: Test Distribution By Location
Table-7: Market Size By Location
Table-8: Typical Pre-Admission Tests
Table-9: Test Volume By Laboratory Discipline
Table-10: Market Size By Laboratory Discipline

More new market research reports by the publisher can be found at Venture Planning Group page.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tanya Rezler
Visit website